Soleno Therapeutics Inc
SLNODelisted May 18, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001484565
Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Soleno Therapeutics Inc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 54
- +31 vs. Q2 2023
- Shares held
- 20.3M
- +15.2M (+298.2%) vs. Q2 2023
- Total value
- $598.8M
- +$577.0M (+2,645.6%) vs. Q2 2023
- New holders
- 36
- 6 more added
- Sold out
- 5
- 8 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLNO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 227 | $2.09B |
| Q4 2025 | 248 | $3.01B |
| Q3 2025 | 240 | $4.41B |
| Q2 2025 | 234 | $4.75B |
| Q1 2025 | 217 | $3.90B |
| Q4 2024 | 166 | $2.29B |
| Q3 2024 | 142 | $2.38B |
| Q2 2024 | 114 | $1.79B |
| Q1 2024 | 98 | $1.52B |
| Q4 2023 | 76 | $1.26B |
| Q3 2023 | 54 | $598.8M |
| Q2 2023 | 23 | $21.8M |
| Q1 2023 | 21 | $7.06M |
| Q4 2022 | 26 | $6.00M |
| Q3 2022 | 22 | $5.23M |
| Q2 2022 | 40 | $8.80M |
| Q1 2022 | 41 | $11.2M |
| Q4 2021 | 39 | $11.8M |
| Q3 2021 | 39 | $27.1M |
| Q2 2021 | 47 | $33.6M |
| Q1 2021 | 63 | $41.2M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Soleno Therapeutics Inc; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 3,203,093 | $94.5M | 11.70% | +3,203,093 | New |
| Perceptive Advisors LLC | 3,074,542 | $90.7M | 3.05% | +866,789+39.3% | Added |
| Carlyle Group Inc. | 2,293,562 | $67.4M | 2.92% | +1,092,056+90.9% | Added |
| Janus Henderson Group PLC | 2,204,053 | $65.0M | 0.04% | +2,204,053 | New |
| Adage Capital Partners GP, L.L.C. | 1,327,000 | $39.2M | 0.09% | +1,327,000 | New |
| Ra Capital Management, L.P. | 1,239,000 | $36.6M | 0.72% | +1,239,000 | New |
| Fairmount Funds Management LLC | 1,142,473 | $33.7M | 4.06% | +1,142,473 | New |
| Commodore Capital LP | 887,500 | $26.2M | 3.06% | +887,500 | New |
| Ikarian Capital, LLC | 536,720 | $15.8M | 5.88% | +536,720 | New |
| Frazier Life Sciences Management, L.P. | 464,937 | $13.7M | 0.91% | +464,937 | New |
| Balyasny Asset Management LLC | 458,823 | $13.5M | 0.04% | +458,823 | New |
| Nantahala Capital Management, LLC | 392,404 | $11.6M | 1.47% | −257,437−39.6% | Reduced |
| Farallon Capital Management, L.L.C. | 388,000 | $11.4M | 0.06% | +388,000 | New |
| Silverarc Capital Management, LLC | 370,000 | $10.9M | 4.07% | +370,000 | New |
| Soleus Capital Management, L.P. | 325,000 | $9.59M | 0.97% | +325,000 | New |
| Woodline Partners LP | 263,860 | $7.79M | 0.09% | +263,860 | New |
| Emerald Advisers, LLC | 248,674 | $7.34M | 0.36% | +248,674 | New |
| Emerald Mutual Fund Advisers Trust | 201,326 | $5.94M | 0.36% | +201,326 | New |
| EAM Investors, LLC | 139,330 | $4.11M | 0.79% | +139,330 | New |
| Logos Global Management LP | 125,000 | $3.69M | 0.53% | +125,000 | New |
| Boothbay Fund Management, LLC | 108,377 | $3.20M | 0.11% | +108,377 | New |
| Parkman Healthcare Partners LLC | 100,000 | $2.95M | 0.54% | +100,000 | New |
| 683 Capital Management, LLC | 87,000 | $2.57M | 0.26% | +87,000 | New |
| J. Goldman & Co LP | 66,000 | $1.95M | 0.10% | −54,799−45.4% | Reduced |
| Renaissance Technologies LLC | 61,554 | $1.82M | 0.00% | −4,500−6.8% | Reduced |
| Millennium Management LLC | 55,456 | $1.64M | 0.00% | +55,456 | New |
| Vanguard Group Inc | 55,251 | $1.63M | 0.00% | +5,312+10.6% | Added |
| Geode Capital Management, LLC | 52,553 | $1.55M | 0.00% | −2,095−3.8% | Reduced |
| Moore Capital Management, LP | 50,000 | $1.48M | 0.04% | +50,000 | New |
| Altium Capital Management LP | 47,081 | $1.39M | 0.80% | +47,081 | New |
| Walleye Capital LLC | 46,244 | $1.36M | 0.02% | +46,244 | New |
| Citadel Advisors LLC | 40,625 | $1.20M | 0.00% | +40,625 | New |
| JPMorgan Chase & Co | 33,176 | $979.0K | 0.00% | +33,170+552,833.3% | Added |
| Morgan Stanley | 33,100 | $976.8K | 0.00% | +33,100 | New |
| Maplelane Capital, LLC | 25,000 | $737.8K | 0.08% | +25,000 | New |
| Maven Securities LTD | 25,000 | $737.8K | 0.08% | +25,000 | New |
| Schonfeld Strategic Advisors LLC | 23,200 | $684.6K | 0.01% | +23,200 | New |
| Dimensional Fund Advisors LP | 20,754 | $612.5K | 0.00% | −4,212−16.9% | Reduced |
| State Street Corp | 15,448 | $455.9K | 0.00% | 00.0% | Unchanged |
| SEI Investments Co | 13,571 | $400.5K | 0.00% | +13,571 | New |
| Captrust Financial Advisors | 10,186 | $300.6K | 0.00% | +10,186 | New |
| Bank of New York Mellon Corp | 9,487 | $280.0K | 0.00% | +9,487 | New |
| Sassicaia Capital Advisers LLC | 8,655 | $255.4K | 12.02% | +8,655 | New |
| Tower Research Capital LLC (TRC) | 7,299 | $215.4K | 0.01% | +6,568+898.5% | Added |
| Northern Trust Corp | 7,030 | $207.5K | 0.00% | +7,030 | New |
| Clayton Partners LLC | 7,000 | $206.6K | 0.18% | +7,000 | New |
| Bank of America Corp | 3,898 | $115.0K | 0.00% | +1,805+86.2% | Added |
| Bollard Group LLC | 2,288 | $68.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 253 | $7.47K | 0.00% | −89−26.0% | Reduced |
| VisionPoint Advisory Group, LLC | 168 | $4.96K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 103 | $3.04K | 0.00% | +103 | New |
| Advisor Group Holdings, Inc. | 71 | $2.10K | 0.00% | −800−91.8% | Reduced |
| Group One Trading, L.P. | 37 | $1.09K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 33 | $974 | 0.00% | −7−17.5% | Reduced |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −364,306−100.0% | Sold out |
| Birchview Capital, LP | 0 | $0 | 0.00% | −245,127−100.0% | Sold out |
| Worth Venture Partners, LLC | 0 | $0 | 0.00% | −90,858−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |